Liesen, Michael P.
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD
Liesen, Michael P., Agoro, R., Swallow, E., Noonan, M., Ni, P., Damrath, J., Wallace, J., Clinkenbeard, E., Allen, M., White, K. , and Hum, Julia
Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) pa- tients as a phosphate (Pi) binder for dialysis-dependent CKD, and for iron de- ficiency anemia (IDA) in non-dialysis CKD. Elevated Pi and IDA...
Article
Work1
Article1
Agoro, R.1
Allen, M.1
Clinkenbeard, E.1
Damrath, J.1
Hum, Julia1
CKD1
GF231
ferric citrate1
iron1
kidney1
English1
The Physiological Society1
20221
Faculty Publications and Research - MUCOM1
Student Publications and Research - MUCOM1
Marian University1